Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
This research is designed to determine if experimental treatment with Antibody-drug conjugate, AZD5335, alone, or in combination with anti-cancer agents is safe, tolerable, and has anti-cancer activity in patients with advanced tumors
Epistemonikos ID: 74cf144cd5ec859b129392231aec9aba098d5536
First added on: May 14, 2024